Home / Latest Reports / Vagal Nerve Stimulators Market

Vagal Nerve Stimulators Market By Product (External VNS Devices and Implantable VNS Devices); Application (Migraine, Epilepsy and Depression); Biomaterial (Polymerics, Metallic and Ceramics) and End-Use (Ambulatory Surgical Centers (ASCS), Hospitals and Others); - Global Industry Analysis And Forecast To 2027

Published On : August 2018 Pages : 180 Category: Healthcare IT Report Code : HC081212

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook

Vagal Nerve Stimulation or Vagus Nerve Stimulation (VNS) is a medical procedure that includes the surgical placement of device under the skin for stimulation of vagal nerve with electrical signals. Vagal nerve is present in the both sides of the body that runs from the brain through neck to chest and abdomen. Vagal nerve acts like a walkie-talkie between brain and gut. Vagal Nerve Stimulation is used for treatment of epilepsy and also depression that do not respond to other treatments. Research I carried out to use Vagal Nerve Stimulation for disorders like; Alzheimer’s, headache, sclerosis, etc. In Vagal Nerve Stimulation, a device is implanted under the skin on the chest and the wire is connected to the left vagal nerve, when this device is operational it send signals along the Vagal Nerve to the brainstem, which in turn sends signals to various parts of brain. Rising financial support to biotechnology and pharmaceutical sectors for R&D, increasing demand for quality treatment, etc. are fueling the growth of Vagal Nerve Simulators Market. These are the factors that, the Vagal Nerve Stimulators Market is anticipated to expand and has tremendous scope during the forecast period. The global Vagal Nerve Stimulators Market is anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Vagal Nerve Stimulators Market is based on segment, by Product the market is segmented into External VNS Devices and Implantable VNS Devices; by Application the market is segmented into Migraine, Epilepsy and Depression; by Biomaterial the market is segmented into Polymerics, Metallic and Ceramics; and by End-Use the market is segmented into Ambulatory Surgical Centers (ASCS), Hospitals and Others.

  • Vagal Nerve Stimulators Market, By Product
  • External VNS Devices
  • Implantable VNS Devices
  • Vagal Nerve Stimulators Market, By Application
  • Migraine
  • Epilepsy
  • Depression
  • Vagal Nerve Stimulators Market, By Biomaterials
  • Polymerics
  • Metallic
  • Ceramics
  • Vagal Nerve Stimulators Market, By End-Use
  • Ambulatory Surgical Centers (ASCS)
  • Hospitals
  • Others

Regional Insights

On a global front, the Vagal Nerve Stimulators Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). The American region is leading global Vagal Nerve Stimulators Market due to factors like; wide R&D, increased government spending on healthcare sector, up-to-date technical structure and rising number of people suffering from neurological disorders.

Vagal Nerve Stimulators Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Inspire Medical Systems Inc., LivaNova PLC, ElectroCore Medical LLC, EnteroMedics Inc., ImThera Medical , Cyberonics, Inc. , NeuroMetrix, Inc., and Boston Scientific Corporation.. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Inspire Medical Systems Inc.
  • LivaNova PLC
  • ElectroCore Medical LLC
  • EnteroMedics Inc.
  • ImThera Medical
  • Cyberonics, Inc.
  • NeuroMetrix, Inc.
  • Boston Scientific Corporation

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Vagal Nerve Stimulators Market, By Product, Estimates and Forecast, 2017-2027 ($Million)

o   External VNS Devices

o   Implantable VNS Devices

o   Vagal Nerve Stimulators Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o   Migraine

o   Epilepsy

o   Depression

o   Vagal Nerve Stimulators Market, By Biomaterial, Estimates and Forecast, 2017-2027 ($Million)

o   Polymerics

o   Metallic

o   Ceramics

o   Vagal Nerve Stimulators Market, By End-Use, Estimates and Forecast, 2017-2027 ($Million)

o   Ambulatory Surgical Centers (ASCS)

o   Hospitals

o   Others

Vagal Nerve Stimulators Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Vagal Nerve Stimulators Market, By Country

o   U.S. Vagal Nerve Stimulators Market

o   Canada Vagal Nerve Stimulators Market

o   Mexico Vagal Nerve Stimulators Market

o   Europe

§  Europe Vagal Nerve Stimulators Market, By Country

o   Germany Vagal Nerve Stimulators Market

o   UK Vagal Nerve Stimulators Market

o   France Vagal Nerve Stimulators Market

o   Russia Vagal Nerve Stimulators Market

o   Italy Vagal Nerve Stimulators Market

o   Rest of Europe Vagal Nerve Stimulators Market

o   Asia-Pacific

§  Asia-Pacific Vagal Nerve Stimulators Market, By Country

o   China Vagal Nerve Stimulators Market

o   Japan Vagal Nerve Stimulators Market

o   South Korea  Vagal Nerve Stimulators Market

o   India Vagal Nerve Stimulators Market

o   Southeast Asia Vagal Nerve Stimulators Market

o   Rest of Asia-Pacific Vagal Nerve Stimulators Market

o   South America

§  South America Vagal Nerve Stimulators Market, By Country

o   Brazil Vagal Nerve Stimulators Market

o   Argentina Vagal Nerve Stimulators Market

o   Columbia Vagal Nerve Stimulators Market

o   Rest of South America Vagal Nerve Stimulators Market

o   Middle East and Africa

§  Middle East and Africa Vagal Nerve Stimulators Market, By Country

o   Saudi Arabia Vagal Nerve Stimulators Market

o   UAE Vagal Nerve Stimulators Market

o   Egypt Vagal Nerve Stimulators Market

o   Nigeria Vagal Nerve Stimulators Market

o   South Africa Vagal Nerve Stimulators Market

o   Rest of MEA Vagal Nerve Stimulators Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Vagal Nerve Stimulators Market, By Product

5.1.     Introduction

5.2.     Global Vagal Nerve Stimulators Revenue and Market Share by Product (2017-2027)

5.2.1.  Global Vagal Nerve Stimulators Revenue and Revenue Share by Product (2017-2027)

5.3.     External VNS Devices

5.3.1.  Global External VNS Devices  Revenue and Growth Rate (2017-2027)

5.4.     Implantable VNS Devices

5.4.1.  Global Implantable VNS Devices Revenue and Growth Rate (2017-2027)

6.       Vagal Nerve Stimulators Market, By Application

6.1.     Introduction

6.2.     Global Vagal Nerve Stimulators Revenue and Market Share by Application (2017-2027)

6.2.1.  Global Vagal Nerve Stimulators Revenue and Revenue Share by Application (2017-2027)

6.3.     Migraine

6.3.1.  Global Migraine Revenue and Growth Rate (2017-2027)

6.4.     Epilepsy

6.4.1.  Global Epilepsy  Revenue and Growth Rate (2017-2027)

6.5.     Depression

6.5.1.  Global Depression Revenue and Growth Rate (2017-2027)

7.       Vagal Nerve Stimulators Market, By Biomaterials

7.1.     Introduction

7.2.     Global Vagal Nerve Stimulators Revenue and Market Share by Biomaterials (2017-2027)

7.2.1.  Global Vagal Nerve Stimulators Revenue and Revenue Share by Biomaterials (2017-2027)

7.3.     Polymerics

7.3.1.  Global Polymerics Revenue and Growth Rate (2017-2027)

7.4.     Metallic

7.4.1.  Global Metallic  Revenue and Growth Rate (2017-2027)

7.5.     Ceramics

7.5.1.  Global Ceramics Revenue and Growth Rate (2017-2027)

8.       Vagal Nerve Stimulators Market, By End-Use

8.1.     Introduction

8.2.     Global Vagal Nerve Stimulators Revenue and Market Share by End-Use (2017-2027)

8.2.1.  Global Vagal Nerve Stimulators Revenue and Revenue Share by End-Use (2017-2027)

8.3.     Ambulatory Surgical Centers (ASCS)

8.3.1.  Global Ambulatory Surgical Centers (ASCS) Revenue and Growth Rate (2017-2027)

8.4.     Hospitals

8.4.1.  Global Hospitals  Revenue and Growth Rate (2017-2027)

8.5.     Others

8.5.1.  Global Others Revenue and Growth Rate (2017-2027)

9.       Vagal Nerve Stimulators Market, By Region

9.1.     Introduction

9.2.     Global Vagal Nerve Stimulators Revenue and Market Share by Regions

9.2.1.  Global Vagal Nerve Stimulators Revenue by Regions (2017-2027)

9.3.     North America Vagal Nerve Stimulators by Countries

9.3.1.  North America Vagal Nerve Stimulators Revenue and Growth Rate (2017-2027)

9.3.2.  North America Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2027)

9.3.3.  United States

9.3.3.1.  United States Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.4.  Canada

9.3.4.1.  Canada Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.5.  Mexico

9.3.5.1.  Mexico Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.     Europe Vagal Nerve Stimulators by Countries

9.4.1.  Europe Vagal Nerve Stimulators Revenue and Growth Rate (2017-2027)

9.4.2.  Europe Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2027)

9.4.3.  Germany

9.4.3.1.  Germany Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.4.  France

9.4.4.1.  France Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.5.  UK

9.4.5.1.  UK Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  Russia

9.4.6.1.  Russia Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  Italy

9.4.7.1.  Italy Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Rest of Europe

9.4.8.1.  Rest of Europe Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.     Asia-Pacific Vagal Nerve Stimulators by Countries

9.5.1.  Asia-Pacific Vagal Nerve Stimulators Revenue and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2027)

9.5.3.  China

9.5.3.1.  China Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.4.  Japan

9.5.4.1.  Japan Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.5.  Korea

9.5.5.1.  Korea Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  India

9.5.6.1.  India Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.7.  Southeast Asia

9.5.7.1.  Southeast Asia Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.  Rest of Asia-Pacific Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.     South America Vagal Nerve Stimulators by Countries

9.6.1.  South America Vagal Nerve Stimulators Revenue and Growth Rate (2017-2027)

9.6.2.  South America Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2027)

9.6.3.  Brazil

9.6.3.1.  Brazil Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.4.  Argentina

9.6.4.1.  Argentina Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.5.  Columbia

9.6.5.1.  Columbia Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Rest of South America

9.6.6.1.  Rest of South America Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.     Middle East and Africa Vagal Nerve Stimulators by Countries

9.7.1.  Middle East and Africa Vagal Nerve Stimulators Revenue and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2027)

9.7.3.  Saudi Arabia

9.7.3.1.  Saudi Arabia Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.4.  United Arab Emirates

9.7.4.1.  United Arab Emirates Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.5.  Egypt

9.7.5.1.  Egypt Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  Nigeria

9.7.6.1.  Nigeria Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  South Africa

9.7.7.1.  South Africa Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Turkey

9.7.8.1.  Turkey Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  Rest of Middle East and Africa

9.7.9.1.  Rest of Middle East and Africa Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

10.    Company Profiles

10.1. Inspire Medical Systems Inc

10.1.1.      Business Overview

10.1.2.       Service Portfolio

10.1.3.      Strategic Developments

10.1.4.       Revenue and Market Share

10.2. LivaNova PLC

10.2.1.      Business Overview

10.2.2.       Service Portfolio

10.2.3.      Strategic Developments

10.2.4.       Revenue and Market Share

10.3. ElectroCore Medical LLC

10.3.1.      Business Overview

10.3.2.       Service Portfolio

10.3.3.      Strategic Developments

10.3.4.       Revenue and Market Share

10.4. EnteroMedics Inc

10.4.1.      Business Overview

10.4.2.       Service Portfolio

10.4.3.      Strategic Developments

10.4.4.       Revenue and Market Share

10.5. ImThera Medical

10.5.1.      Business Overview

10.5.2.       Service Portfolio

10.5.3.      Strategic Developments

10.5.4.       Revenue and Market Share

10.6. Cyberonics, Inc

10.6.1.      Business Overview

10.6.2.       Service Portfolio

10.6.3.      Strategic Developments

10.6.4.       Revenue and Market Share

10.7. NeuroMetrix, Inc

10.7.1.      Business Overview

10.7.2.       Service Portfolio

10.7.3.      Strategic Developments

10.7.4.       Revenue and Market Share

10.8. Boston Scientific Corporation

10.8.1.      Business Overview

10.8.2.       Service Portfolio

10.8.3.      Strategic Developments

10.8.4.       Revenue and Market Share

11.    Global Vagal Nerve Stimulators Market Competition, by Manufacturer

11.1. Global Vagal Nerve Stimulators Revenue and Market Share by Manufacturer (2017-2017)

11.2. Global Vagal Nerve Stimulators Price By Region (2017-2017)

11.3. Top 5 Vagal Nerve Stimulators Manufacturer Market Share

11.4. Market Competition Trend

12.    Vagal Nerve Stimulators Market Forecast (2017-2027)

12.1. Global Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2027)

12.2. Vagal Nerve Stimulators Market Forecast by Regions (2017-2027)

12.2.1.      North America Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.1.1. United States Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.1.2. Canada Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.1.3. Mexico Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.2.      Europe Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.2.1. Germany Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.2.2. France Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.2.3. UK Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.2.4. Russia Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.2.5. Italy Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.2.6. Rest of Europe Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.3.      Asia-Pacific Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.3.1. China Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.3.2. Japan Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.3.3. Korea Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.3.4. India Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.3.5. Southeast Asia Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.3.6. Rest of Asia-Pacific Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.4.      South America Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.4.1. Brazil Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.4.2. Argentina Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.4.3. Columbia Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.4.4. Rest of South America Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.5.      Middle East and Africa Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.5.1. Saudi Arabia Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.5.2. United Arab Emirates Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.5.3. Egypt Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.5.4. Nigeria Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.5.5. South Africa Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.5.6. Turkey Vagal Nerve Stimulators Market Forecast (2017-2027)

12.2.5.7. Rest of Middle East and Africa Vagal Nerve Stimulators Market Forecast (2017-2027)

12.3. Vagal Nerve Stimulators Market Forecast by Product (2017-2027)

12.3.1.      Vagal Nerve Stimulators Forecast by Product (2017-2027)

12.3.2.      Vagal Nerve Stimulators Market Share Forecast by Product (2017-2027)

12.4. Vagal Nerve Stimulators Market Forecast by Application (2017-2027)

12.4.1.      Vagal Nerve Stimulators Forecast by Application (2017-2027)

12.4.2.      Vagal Nerve Stimulators Market Share Forecast by Application (2017-2027)

12.5. Vagal Nerve Stimulators Market Forecast by Biomaterials (2017-2027)

12.5.1.      Vagal Nerve Stimulators Forecast by Biomaterials (2017-2027)

12.5.2.      Vagal Nerve Stimulators Market Share Forecast by Biomaterials (2017-2027)

12.6. Vagal Nerve Stimulators Market Forecast by End-Use (2017-2027)

12.6.1.      Vagal Nerve Stimulators Forecast by End-Use (2017-2027)

12.6.2.      Vagal Nerve Stimulators Market Share Forecast by End-Use (2017-2027)

List of Tables

13. List of Tables and Figures

Figure United States Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Canada Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Mexico Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Germany Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure France Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure UK Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Russia Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Italy Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Europe Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure China Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Japan Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Korea Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure India Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Southeast Asia Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Asia-Pacific Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Brazil Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Argentina Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Columbia Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of South America Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Saudi Arabia Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure United Arab Emirates Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Egypt Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Nigeria Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure South Africa Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Turkey Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Middle East and Africa Vagal Nerve Stimulators Revenue (Million USD) and Growth Rate (2017-2025)

Table Global Vagal Nerve Stimulators Revenue and Revenue Share by Product (2017-2018)

Figure Global External VNS Devices Revenue and Growth Rate (2017-2018)

Figure Global Implantable VNS Devices Revenue and Growth Rate (2017-2018)

Table Global Vagal Nerve Stimulators Revenue and Revenue Share by Application (2017-2018)

Figure Global Migraine Revenue and Growth Rate (2017-2018)

Figure Global Epilepsy Revenue and Growth Rate (2017-2018)

Figure Global Depression Revenue and Growth Rate (2017-2018)

Table Global Vagal Nerve Stimulators Revenue and Revenue Share by Biomaterials (2017-2018)

Figure Global Polymerics Revenue and Growth Rate (2017-2018)

Figure Global Metallic Revenue and Growth Rate (2017-2018)

Figure Global Ceramics Revenue and Growth Rate (2017-2018)

Table Global Vagal Nerve Stimulators Revenue and Revenue Share by End-Use (2017-2018)

Figure Global Ambulatory Surgical Centers (ASCS) Revenue and Growth Rate (2017-2018)

Figure Global Hospitals Revenue and Growth Rate (2017-2018)

Figure Global Others Revenue and Growth Rate (2017-2018)

Table Global Vagal Nerve Stimulators Revenue by Regions (2017-2018)

Figure North America Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure North America Vagal Nerve Stimulators Revenue and Growth Rate (2017-2018)

Figure North America Vagal Nerve Stimulators by Countries (2017-2018)

Figure North America Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2018)

Figure United States Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure United States Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Canada Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Canada Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Mexico Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Mexico Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Europe Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Europe Vagal Nerve Stimulators Revenue and Growth Rate (2017-2018)

Figure Europe Vagal Nerve Stimulators by Countries (2017-2018)

Figure Europe Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2018)

Figure Germany Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Germany Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure France Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure France Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure UK Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure UK Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Russia Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Russia Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Italy Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Italy Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Europe Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Rest of Europe Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Asia-Pacific Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Asia-Pacific Vagal Nerve Stimulators Revenue and Growth Rate (2017-2018)

Figure Asia-Pacific Vagal Nerve Stimulators by Countries (2017-2018)

Figure Asia-Pacific Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2018)

Figure China Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure China Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Japan Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Japan Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Korea Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Korea Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure India Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure India Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Southeast Asia Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Southeast Asia Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South America Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure South America Vagal Nerve Stimulators Revenue and Growth Rate (2017-2018)

Figure South America Vagal Nerve Stimulators by Countries (2017-2018)

Figure South America Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2018)

Figure Brazil Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Brazil Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Argentina Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Argentina Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Columbia Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Columbia Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of South America Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Rest of South America Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Middle East and Africa Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Middle East and Africa Vagal Nerve Stimulators Revenue and Growth Rate (2017-2018)

Figure Middle East and Africa Vagal Nerve Stimulators by Countries (2017-2018)

Figure Middle East and Africa Vagal Nerve Stimulators Revenue (Million USD) by Countries (2017-2018)

Figure Saudi Arabia Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Saudi Arabia Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure United Arab Emirates Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure United Arab Emirates Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Egypt Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Egypt Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Nigeria Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Nigeria Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South Africa Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure South Africa Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Turkey Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Turkey Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Vagal Nerve Stimulators Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2017-2018)

Table Inspire Medical Systems Inc Vagal Nerve Stimulators Price, Revenue, Gross Margin and Market Share (2017-2017)

Table LivaNova PLC Vagal Nerve Stimulators Price, Revenue, Gross Margin and Market Share (2017-2017)

Table ElectroCore Medical LLC Vagal Nerve Stimulators Price, Revenue, Gross Margin and Market Share (2017-2017)

Table EnteroMedics Inc Vagal Nerve Stimulators Price, Revenue, Gross Margin and Market Share (2017-2017)

Table ImThera Medical Vagal Nerve Stimulators Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Cyberonics, Inc Vagal Nerve Stimulators Price, Revenue, Gross Margin and Market Share (2017-2017)

Table NeuroMetrix, Inc Vagal Nerve Stimulators Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Boston Scientific Corporation Vagal Nerve Stimulators Price, Revenue, Gross Margin and Market Share (2017-2017)

Figure Global Vagal Nerve Stimulators Market Share by Manufacturer

Figure Global Vagal Nerve Stimulators Revenue and Market Share by Manufacturer

Table Global Vagal Nerve Stimulators Price by Region (2017-2017)

Figure Top 5 Vagal Nerve Stimulators Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Vagal Nerve Stimulators Revenue (Millions USD) and Growth Rate (2018-2025)

Table Vagal Nerve Stimulators Market Forecast by Regions (2018-2025)

Figure North America Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure United States Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Canada Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Mexico Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Europe Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Germany Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure France Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure UK Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Russia Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Italy Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Rest of Europe Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Asia-Pacific Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure China Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Japan Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Korea Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure India Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Southeast Asia Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure South America Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Brazil Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Argentina Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Columbia Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Rest of South America Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Middle East and Africa Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Saudi Arabia Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure United Arab Emirates Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Egypt Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Nigeria Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure South Africa Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Turkey Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Vagal Nerve Stimulators Market Forecast (2018-2025)

Figure Global Vagal Nerve Stimulators Forecast by Product (2018-2025)

Figure Global Vagal Nerve Stimulators Market Share Forecast by Product (2018-2025)

Figure Global Vagal Nerve Stimulators Forecast by Product (2018-2025)

Figure Global Vagal Nerve Stimulators Forecast by Application (2018-2025)

Figure Global Vagal Nerve Stimulators Market Share Forecast by Application (2018-2025)

Figure Global Vagal Nerve Stimulators Forecast by Application (2018-2025)

Figure Global Vagal Nerve Stimulators Forecast by Biomaterials (2018-2025)

Figure Global Vagal Nerve Stimulators Market Share Forecast by Biomaterials (2018-2025)

Figure Global Vagal Nerve Stimulators Forecast by Biomaterials (2018-2025)

Figure Global Vagal Nerve Stimulators Forecast by End-Use (2018-2025)

Figure Global Vagal Nerve Stimulators Market Share Forecast by End-Use (2018-2025)

Figure Global Vagal Nerve Stimulators Forecast by End-Use (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*